BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta S, Buttar HS, Kaur G, Tuli HS. Baicalein: promising therapeutic applications with special reference to published patents. Pharm Pat Anal 2022. [PMID: 35345898 DOI: 10.4155/ppa-2021-0027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Nian M, Qiao H, Yang X, Wu S, Zheng X. Review of bioactivity and structure-activity relationship on baicalein (5,6,7-trihydroxyflavone) and scutellarin (5,7-dihydroxy-8-methoxyflavone) derivatives: Structural modifications inspired from flavonoids in Scutellaria baicalensis. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tuli H, Garg VK, Kapoor D, Bansal P, Kumar P, Mohapatra RK, Dhama K, Vashishth A, Seth P, Bhatia GK. In silico targeting of osmoporin protein of Salmonella to identify anti-Salmonellosis phyto-compounds. J Exp Bio & Ag Sci 2022;10:423-429. [DOI: 10.18006/2022.10(2).423.429] [Reference Citation Analysis]
3 Liu Z, Dong WT, Wei WF, Huo JH, Wang WM. Exploring the mechanism of Qinbaiqingfei-concentrate pills in the treatment of Mycoplasma pneumoniae pneumonia from the perspective of intestinal microbiota and mucosal immunity. J Ethnopharmacol 2022;293:115308. [PMID: 35460847 DOI: 10.1016/j.jep.2022.115308] [Reference Citation Analysis]